Pfizer Korea unveils Norvasc ODT

Published: 2013-03-21 06:56:00

Updated: 2013-03-21 06:56:00

Pfizer Korea, a Korean unit of the U.S. based Pfizer Inc., said Tuesday it has started selling the oral disintegrating tablets (5 mg, 10 mg) of Norvasc (amlodipine besylate) here, adding another dosage form to its Norvasc line-up. The new dosage form is now available in Japan.

The most popular...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK